Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain - Journal of Pain and Symptom Management
Sativex fails to meet primary end point in latest clinical trial
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial - The Lancet Neurology
US FDA grants Sativex fast track status for cancer pain
GW Pharma Extends Recruitment for Pivotal Trials of Sativex in MS
Nabiximols - Wikipedia
Nabiximols for Multiple Sclerosis Clinical Trial 2022 | Power
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial - The Journal of Pain
Everything you need to know about Sativex, the first cannabis-based drug to be globally standardised
Third Phase 3 Trial of Sativex, Cannabis Extract for MS Spasticity, Planned
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
Sativex fails to meet primary end point in latest clinical trial
At Long Last Sativex? | O'Shaughnessy's
![PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ff46d50dfc6424b75848bde31bd6ab11bd240824/3-Figure1-1.png "PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar")
PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
A double blind, randomised, placebo controlled trial of Sativex® for the management of cannabis withdrawal | NDARC - National Drug and Alcohol Research Centre
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity | Semantic Scholar
Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial - The Lancet Neurology
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
GW Pharma Phase 3 Trials for Sativex Miss Endpoints – New Cannabis Ventures
PDF) Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial
